Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



Study Evaluating mCRPC Treatment Using PSMA [Lu-177]-PNT2002 Therapy After Second-line Hormonal Treatment

Prostate

The purpose of this study is to evaluate the efficacy and safety of [Lu-177]-PNT2002 in patients with metastatic castration-resistant prostate cancer who have progressed following treatment with androgen receptor axis-targeted therapy (ARAT).
Prostate
III
Schaffer, Kerry
NCT04647526
VICCURO20124

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: